Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Breast Cancer

Free Subscription 21.12.2019 1 Am J Surg 1 Br J Cancer 1 Breast J 1 Cancer 1 Cancer Chemother Pharmacol 1 Clin Breast Cancer 2 Clin Cancer Res 1 Eur J Cancer 1 Gene 2 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 J Nucl Med 1 Lancet 2 Lancet Oncol 1 Nat Rev Clin Oncol 1 NPJ Breast Cancer 1 Oncogene 1 PLoS Genet 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. CROWN A, Rocha FG, Grumley JW
   Intraoperative radiation therapy in early-stage breast cancer: Presence of lobular features is not associated with increased rate of requiring additional therapy.
   Am J Surg. 2019 Nov 11. pii: S0002-9610(19)31293.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

2. HUNTER FW, Barker HR, Lipert B, Rothe F, et al
   Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer.
   Br J Cancer. 2019 Dec 16. pii: 10.1038/s41416-019-0635.
   PubMed     Text format     Abstract available
   
   

   
   Breast J

3. GIARRATANO T, Frezzini S, Zanocco M, Giorgi CA, et al
   Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
   Breast J. 2019 Dec 14. doi: 10.1111/tbj.13711.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

4. AFIFI AM, Saad AM, Al-Husseini MJ, Elmehrath AO, et al
   Causes of death after breast cancer diagnosis: A US population-based analysis.
   Cancer. 2019 Dec 16. doi: 10.1002/cncr.32648.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Chemother Pharmacol

5. HUANG L, Wang X, Zhou L, Di L, et al
   Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer.
   Cancer Chemother Pharmacol. 2019 Dec 14. pii: 10.1007/s00280-019-04000.
   PubMed     Text format     Abstract available
   
   

   
   Clin Breast Cancer

6. RUGO HS, Finn RS, Gelmon K, Joy AA, et al
   Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozol
   Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30668.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

7. ROBERTSON JF, Coleman RE, Cheung KL, Evans A, et al
   Proliferation and AKT activity biomarker analyses after Capivasertib (AZD5363) treatment of patients with ER+ invasive breast cancer (STAKT).
   Clin Cancer Res. 2019 Dec 13. pii: 1078-0432.CCR-19-3053.
   PubMed     Text format     Abstract available
   
   
8. SIMS AH, Leggate M, Campbell A
   Exercise Window Trial in Newly Diagnosed Breast Cancer-Letter.
   Clin Cancer Res. 2019;25:7609-7610.
   PubMed     Text format    
   
   

   
   Eur J Cancer

9. MIERZYNSKA J, Taye M, Pe M, Coens C, et al
   Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.
   Eur J Cancer. 2019;125:69-82.
   PubMed     Text format     Abstract available
   
   

   
   Gene

10. AL-EITAN LN, Rababa'h DM
    Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.
    Gene. 2019 Dec 10:144281. doi: 10.1016/j.gene.2019.144281.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

11. GUO X, Long J, Chen Z, Shu XO, et al
    Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32825.
    PubMed     Text format     Abstract available
    
    
12. ZHANG D, Nichols HB, Troester M, Cai J, et al
    Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32824.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

13. AGARWAL A, Peterson J, Hoyle LM, Marks LB, et al
    Variations in Medicaid Payment Rates for Radiation Oncology.
    Int J Radiat Oncol Biol Phys. 2019;104:488-493.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

14. SCHMID P, Abraham J, Chan S, Wheatley D, et al
    Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
    J Clin Oncol. 2019 Dec 16:JCO1900368. doi: 10.1200/JCO.19.00368.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

15. MCDONALD ES, Doot RK, Young AJ, Schubert EK, et al
    Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.232363. doi: 10.2967/jnumed.119.232363.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

16. CUZICK J, Sestak I, Forbes JF, Dowsett M, et al
    Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
    Lancet. 2019 Dec 11. pii: S0140-6736(19)32955.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

17. CRISTOFANILLI M
    Time for a shift in molecular down staging in luminal breast cancer.
    Lancet Oncol. 2019 Dec 11. pii: S1470-2045(19)30806.
    PubMed     Text format    
    
    
18. PRAT A, Saura C, Pascual T, Hernando C, et al
    Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
    Lancet Oncol. 2019 Dec 11. pii: S1470-2045(19)30786.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Clin Oncol

19. GOUTSOULIAK K, Veeraraghavan J, Sethunath V, De Angelis C, et al
    Towards personalized treatment for early stage HER2-positive breast cancer.
    Nat Rev Clin Oncol. 2019 Dec 13. pii: 10.1038/s41571-019-0299.
    PubMed     Text format     Abstract available
    
    

    
    NPJ Breast Cancer

20. VIDULA N, Yau C, Wolf D, Rugo HS, et al
    Androgen receptor gene expression in primary breast cancer.
    NPJ Breast Cancer. 2019;5:47.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

21. FANG R, Xu F, Shi H, Wu Y, et al
    LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Oncogene. 2019 Dec 13. pii: 10.1038/s41388-019-1146.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

22. CORTEZ LM, Brown AL, Dennis MA, Collins CD, et al
    APOBEC3A is a prominent cytidine deaminase in breast cancer.
    PLoS Genet. 2019;15:e1008545.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

23. ROMAN M, Sala M, Domingo L, Posso M, et al
    Personalized breast cancer screening strategies: A systematic review and quality assessment.
    PLoS One. 2019;14:e0226352.
    PubMed     Text format     Abstract available
    
    
24. TALMONT F, Mouledous L, Baranger M, Gomez-Brouchet A, et al
    Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.
    PLoS One. 2019;14:e0213203.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: